Veterinary Medicines

Vigophos 100 mg / ml + 0.05 mg / ml solution for injection for cattle

Authorised
  • Cyanocobalamin
  • Butafosfan
Download as PDF

Product identification

Medicine name:
Vigophos 100 mg / ml + 0.05 mg / ml solution for injection for cattle
Vigophos 100 mg/ml Oplossing voor injectie
Vigophos 100 mg/ml Solution injectable
Vigophos 100 mg/ml Injektionslösung
Active substance:
  • Cyanocobalamin
  • Butafosfan
Target species:
  • Cattle
Route of administration:
  • Intravenous use

Product details

Active substance and strength:
  • Cyanocobalamin
    0.05
    milligram(s)
    /
    1.00
    millilitre(s)
  • Butafosfan
    100.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intravenous use
    • Cattle
      • Meat and offal
        0
        day
      • Milk
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA12CX99
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Belgium
Available in:
  • Belgium
Package description:
  • Carton containing 12 Type II amber glass vials of 100 ml closed with a coated bromobutyl or chlorobutyl rubber stopper and sealed with an aluminium cap
  • Carton containing 6 Type II amber glass vial of 100 ml closed with a coated bromobutyl or chlorobutyl rubber stopper and sealed with an aluminium cap
  • Carton containing 1 Type II amber glass vial of 100 ml closed with a coated bromobutyl or chlorobutyl rubber stopper and sealed with an aluminium cap

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Industrial Veterinaria S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • aniMedica GmbH
  • Industrial Veterinaria S.A.
  • aniMedica Herstellungs GmbH
Responsible authority:
  • Federal Agency For Medicines And Health Products
Authorisation number:
  • BE-V530960
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0426/001
Concerned member states:
  • Austria
  • Belgium
  • Czechia
  • Denmark
  • Germany
  • Hungary
  • Ireland
  • Italy
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 17/08/2025
Download
French (PDF)
Published on: 17/08/2025
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 18/08/2025
Download
French (PDF)
Published on: 18/08/2025
Download
German (PDF)
Published on: 18/08/2025
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 17/04/2025
Download
French (PDF)
Published on: 17/04/2025
Download
German (PDF)
Published on: 17/04/2025
Download

Combined File of all Documents

English (PDF)
Published on: 11/11/2025
Download

PuAR updated.pdf

English (PDF)
Published on: 26/02/2024
Download